Marianne De Backer - Jun 12, 2024 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role
Chief Executive Officer, Director
Signature
/s/ Vanina de Verneuil, Attorney-In-Fact
Stock symbol
VIR
Transactions as of
Jun 12, 2024
Transactions value $
$0
Form type
4
Date filed
6/12/2024, 04:00 PM
Previous filing
Apr 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Other $0 -53.1K -7.83% $0.00 625K Jun 12, 2024 Direct F1
transaction VIR Common Stock Other $0 +53.1K $0.00 53.1K Jun 12, 2024 See Footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transfer without consideration for tax planning purposes.
F2 The shares are held in the name of the Ureel-De Backer Family Trust, of which the reporting person and her spouse are Trustees.